Clinical Trials Browser

Phase 2 × SCLC × olaparib × Clear all

NCT03428607 2021-02-18

Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]

Phase 2 Completed

SCLC